These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24180745)

  • 61. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bexarotene prodrugs: targeting through cleavage by NQO1 (DT-diaphorase).
    Schäfer A; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1944-7. PubMed ID: 24666648
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.
    Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M
    Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.
    Hamada T; Sugaya M; Tokura Y; Ohtsuka M; Tsuboi R; Nagatani T; Tani M; Setoyama M; Matsushita S; Kawai K; Yonekura K; Yoshida T; Saida T; Iwatsuki K
    J Dermatol; 2017 Feb; 44(2):135-142. PubMed ID: 27543197
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.
    Zhu J; Hu L; Li L; Huang X; Shi H
    Toxicol Appl Pharmacol; 2017 Sep; 330():40-47. PubMed ID: 28689802
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
    Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
    J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
    Dummer R; Beyer M; Hymes K; Epping MT; Bernards R; Steinhoff M; Sterry W; Kerl H; Heath K; Ahern JD; Hardwick JS; Garcia-Vargas J; Baumann K; Rizvi S; Frankel SR; Whittaker SJ; Assaf C
    Leuk Lymphoma; 2012 Aug; 53(8):1501-8. PubMed ID: 22239668
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Action mechanism of retinoid-synergistic dibenzodiazepines.
    Umemiya H; Kagechika H; Fukasawa H; Kawachi E; Ebisawa M; Hashimoto Y; Eisenmann G; Erb C; Pornon A; Chambon P; Gronemeyer H; Shudo K
    Biochem Biophys Res Commun; 1997 Apr; 233(1):121-5. PubMed ID: 9144408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.
    Querfeld C; Rosen ST; Guitart J; Rademaker A; Fung BB; Posten W; Kuzel TM
    J Am Acad Dermatol; 2004 Jul; 51(1):25-32. PubMed ID: 15243520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety.
    Takamatsu K; Takano A; Yakushiji N; Morishita K; Matsuura N; Makishima M; Ali HI; Akaho E; Tai A; Sasaki K; Kakuta H
    ChemMedChem; 2008 Mar; 3(3):454-60. PubMed ID: 18157857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Retinoid X receptor ligands: a patent review (2007 - 2013).
    Yamada S; Kakuta H
    Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists.
    Alvarez R; Vega MJ; Kammerer S; Rossin A; Germain P; Gronemeyer H; de Lera AR
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6117-22. PubMed ID: 15546741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
    J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
    Sanchez PV; Glantz ST; Scotland S; Kasner MT; Carroll M
    Leukemia; 2014 Apr; 28(4):749-60. PubMed ID: 23823656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.
    Li D; Li T; Wang F; Tian H; Samuels HH
    Mol Cell Biol; 2002 Aug; 22(16):5782-92. PubMed ID: 12138189
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.
    Lalloyer F; Pedersen TA; Gross B; Lestavel S; Yous S; Vallez E; Gustafsson JA; Mandrup S; Fiévet C; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1488-95. PubMed ID: 19592467
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.
    Umemiya H; Fukasawa H; Ebisawa M; Eyrolles L; Kawachi E; Eisenmann G; Gronemeyer H; Hashimoto Y; Shudo K; Kagechika H
    J Med Chem; 1997 Dec; 40(26):4222-34. PubMed ID: 9435893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.
    Lin JH; Kim EJ; Bansal A; Seykora J; Richardson SK; Cha XY; Zafar S; Nasta S; Wysocka M; Benoit B; Rook AH; Fakharzadeh SS
    Blood; 2008 Sep; 112(6):2484-8. PubMed ID: 18559673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.